Clinical trial for the prevention of osteonecrosis of the femoral head secondary to the initial corticosteroid treatment in patients with systemic lupus erythematosus

Trial Profile

Clinical trial for the prevention of osteonecrosis of the femoral head secondary to the initial corticosteroid treatment in patients with systemic lupus erythematosus

Recruiting
Phase of Trial: Phase II

Latest Information Update: 12 May 2016

At a glance

  • Drugs Clopidogrel (Primary) ; Pitavastatin (Primary) ; Tocopherol acetate (Primary)
  • Indications Osteonecrosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Sep 2014 Actual initiation date changed from 1 Oct 2012 to 1 Aug 2014, according to University Hospital Medical Information Network - Japan record.
    • 24 Sep 2014 The dose of pitavastatin calcium has been changed from 4mg/day to 2 mg/day, according to University Hospital Medical Information Network - Japan record.
    • 24 Sep 2014 Planned End Date changed from 1 Oct 2015 to 1 Aug 2016, according to University Hospital Medical Information Network - Japan record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top